Nintedanib for treatment of progressive interstitial lung disease after peripheral blood stem cell transplantation in a patient with recurrent acute lymphoblastic leukemia

Pediatr Blood Cancer. 2021 Nov;68(11):e29211. doi: 10.1002/pbc.29211. Epub 2021 Jul 1.

Authors

Masahiko Kouroki¹, Jiro Inagaki¹, Toru Fujisaki¹, Toshiya Matsuishi¹, Tetsuji Sato¹, Junji Kamizono¹, Masahiro Yasui¹

Affiliation

¹ Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan.

PMID: 34197046
DOI: 10.1002/pbc.29211

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Humans
Indoles / therapeutic use*
Lung Diseases, Interstitial* / drug therapy
Lung Diseases, Interstitial* / etiology
Peripheral Blood Stem Cell Transplantation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / complications
Recurrence

Substances

Indoles
nintedanib